Comment on FR Doc # 2026-10128
Premier, Inc.SupportAdvocacy
Summary: Premier Inc., a healthcare improvement company and supply chain leader, supports the DEA's proposed revisions but argues that the current quota system is insufficient to address drug shortages. They advocate for a more flexible, demand-driven quota process, the creation of a Chief Pharmacy Officer within the DEA, and better coordination between API and finished-dose manufacturers to ensure patient access to critical medications.
Please see Premier Inc.'s detailed comment letter attached.